Lineage Cell Therapeutics
LCTX
LCTX
69 hedge funds and large institutions have $152M invested in Lineage Cell Therapeutics in 2015 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 22 increasing their positions, 12 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
17% more funds holding
Funds holding: 59 → 69 (+10)
0.07% more ownership
Funds ownership: 45.47% → 45.54% (+0.07%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
69
Holding in Top 10
1
Calls
$2.58M
Puts
$478K
Top Buyers
| 1 | +$683K | |
| 2 | +$404K | |
| 3 | +$323K | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$254K |
| 5 |
State Street
Boston,
Massachusetts
|
+$253K |
Top Sellers
| 1 | -$2.22M | |
| 2 | -$328K | |
| 3 | -$185K | |
| 4 |
SCP
Seizert Capital Partners
Birmingham,
Michigan
|
-$73K |
| 5 |
Bank of New York Mellon
New York
|
-$56.3K |